Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-09

Clinical Trial Update: Imaging the Migraine Brain Pre- and Post-Erenumab [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating imaging of the migraine brain before and after erenumab completion with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • erenumab (erenumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2024-01-09